ROBERT L. VAN NOSTRAND

Profile

First Name

: ROBERT

Middle Name

: L.

Last Name

: VAN NOSTRAND

Related Companies
Titles
Company Name
Related People
DIRECTOR
ACHILLION PHARMACEUTICALS INC
MILIND S. DESHPANDE, MARY KAY FENTON, JASON S. FISHERMAN, GARY E. FRASHIER, MICHAEL GREY, MICHAEL D. KISHBAUCH, DENNIS C. LIOTTA, ELIZABETH OLEK, DAVID I. SCHEER, GAUTAM SHAH, NICHOLAS J. SIMON, JOSEPH TRUITT, DAVID P. WRIGHT
DIRECTOR
METABOLIX, INC.
CELESTE BEEKS MASTIN, LYNNE BRUM, LYNNE H. BRUM, SARAH P. CECIL, CHARLES B. HAASER, RICHARD W. HAMILTON, JOSEPH D. HILL, PETER N. KELLOGG, OLIVER P. PEOPLES, JOSEPH SHAULSON, ANTHONY J. SINSKEY, KRISTI D. SNELL, MATTHEW STROBECK, JOHAN VAN WALSEM
DIRECTOR
ENUMERAL BIOMEDICAL HOLDINGS, INC.
DEREK BRAND, BARRY BUCKLAND, BARRY BUCKLAND, PH.D., ROBERT J. EASTON, WAEL FAYAD, ANHCO NGUYEN, ANHCO NGUYEN, PH.D., ALLAN ROTHSTEIN, ALLAN P. ROTHSTEIN, JOHN J. RYDZEWSKI, KEVIN SARNEY, KEVIN G. SARNEY, PAUL J. SEKHRI, ARTHUR H. TINKELENBERG, ARTHUR H. TINKELENBERG, PH.D., DANIEL B. WOLFE
DIRECTOR
YIELD10 BIOSCIENCE, INC.
CELESTE BEEKS MASTIN, LYNNE BRUM, LYNNE H. BRUM, SARAH P. CECIL, CHARLES B. HAASER, RICHARD W. HAMILTON, JOSEPH D. HILL, PETER N. KELLOGG, OLIVER P. PEOPLES, JOSEPH SHAULSON, ANTHONY J. SINSKEY, KRISTI D. SNELL, MATTHEW STROBECK, JOHAN VAN WALSEM
DIRECTOR
SELLAS LIFE SCIENCES GROUP, INC.
MARK J. AHN, PH.D., WILLIAM L. ASHTON, JOHN T. BURNS, RICHARD CHIN, RICHARD CHIN, M.D., RYAN DUNLAP, IRVING M. EINHORN, STEPHEN GALLIKER, STEPHEN S. GALLIKER, MARY ANN GRAY, MARY ANN GRAY, PH.D., BRIAN HAMILTON, M.D., PH.D., SANFORD J. HILLSBERG, KATHERINE BACH KALIN, THOMAS J. KNAPP, STEVEN A. KRIEGSMAN, BIJAN NEJADNIK, BIJAN NEJADNIK, M.D., RUDOLPH NISI, RUDOLPH NISI, M.D., ROBERT VAN NOSTRAND, DAVID A. SCHEINBERG, MARK W. SCHWARTZ, MARK W. SCHWARTZ, PH.D., ANGELOS M. STERGIOU, JOHN VARIAN, JANE WASMAN, BARBARA A. WOOD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-08-31
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-31 
2017-07-14
D
Link
OTHER 
MISCELLANEOUS PLASTIC PRODUCTS [3080] 
DECLINE TO DISCLOSE 
Equity 
2017-07-07 
2017-05-25
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2017-05-19 
2016-12-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2016-12-09 
2016-08-02
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-07-29 
2014-09-08
D
Link
OTHER 
MISCELLANEOUS PLASTIC PRODUCTS [3080] 
DECLINE TO DISCLOSE 
Equity 
2014-08-22 
2010-08-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-08-20